+1 628 258 0071(US) +44
2035 002 764(UK)
Search For Reports
GET FREE SAMPLE R
Home / Reports / Pharmaceutical
/ Anti Viral Drugs
Please note that the assessment period of report has been updated from 2013- 2022 to 2020-2027. Cordially fill Sample
form for updated data.
Market Synopsis of Global Anti-Viral Drugs Market:
Viruses are the ultimate parasites as they derive nutrition from the host cell and also hijack and direct its
metabolic machinery to synthesize new virus particles. Viruses can live and replicate only inside host body.
Anti-viral drugs are specifically used to treat viral infections and act mostly by inhibiting their target viruses.
The growth of antiviral drugs market is driven by factors such as rise in healthcare expenditure, growing
research and development investment, emergence of virus life-threatening diseases like bird flu, strong
development pipeline and increasing incidence rates of viral infections particularly HIV. WHO estimates 36.7
million people are suffering from HIV/AIDS worldwide with 1.1 million deaths of AIDS-related illnesses in 2015.
Taking all these factors the market for anti-viral drugs is expected to reach $62.67 billion by the end of the forecast
period growing at a CAGR of 6.9%.
Global Anti-Viral Drugs Market, by Application, 2015 (%):
Study Objectives Global Anti-Viral Drugs Market:
To provide detail analysis of the market structure along with forecast for the next 7 years of the
various segments and sub-segments of the global anti-viral drugs market
To provide insights about factors affecting the market growth
To analyze the market based on various factors- price analysis, supply chain analysis, porters five force
To provide historical and forecast revenue of the market segments and sub-segments with respect to
four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide country level analysis of the market with respect to th